Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Silodosin is effective for treatment of LUTS in men with BPH: a systematic review.

Ding H, Du W, Hou ZZ, Wang HZ, Wang ZP.

Asian J Androl. 2013 Jan;15(1):121-8. doi: 10.1038/aja.2012.102. Epub 2012 Dec 10. Review.

PMID:
23223034
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

WITHDRAWN: Tamsulosin for benign prostatic hyperplasia.

Wilt TJ, Macdonald R, Rutks I.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD002081. doi: 10.1002/14651858.CD002081.pub2. Review.

PMID:
21901681
[PubMed - indexed for MEDLINE]
3.

Tamsulosin for benign prostatic hyperplasia.

Wilt TJ, Mac Donald R, Rutks I.

Cochrane Database Syst Rev. 2003;(1):CD002081. Review. Update in: Cochrane Database Syst Rev. 2011;(9):CD002081.

PMID:
12535426
[PubMed - indexed for MEDLINE]
4.

The efficacy and safety of silodosin in treating BPH: a systematic review and meta-analysis.

Cui Y, Zong H, Zhang Y.

Int Urol Nephrol. 2012 Dec;44(6):1601-9. doi: 10.1007/s11255-012-0261-6. Epub 2012 Aug 24. Review.

PMID:
22914879
[PubMed - indexed for MEDLINE]
5.

Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia.

Schilit S, Benzeroual KE.

Clin Ther. 2009 Nov;31(11):2489-502. doi: 10.1016/j.clinthera.2009.11.024. Review.

PMID:
20109995
[PubMed - indexed for MEDLINE]
6.

Finasteride for benign prostatic hyperplasia.

Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD006015. doi: 10.1002/14651858.CD006015.pub3. Review.

PMID:
20927745
[PubMed - indexed for MEDLINE]
7.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD001423. doi: 10.1002/14651858.CD001423.pub3. Review.

PMID:
23235581
[PubMed - indexed for MEDLINE]
8.

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.

Garimella PS, Fink HA, Macdonald R, Wilt TJ.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007360. doi: 10.1002/14651858.CD007360.pub2. Review.

PMID:
19821408
[PubMed - indexed for MEDLINE]
9.

A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.

Gacci M, Corona G, Salvi M, Vignozzi L, McVary KT, Kaplan SA, Roehrborn CG, Serni S, Mirone V, Carini M, Maggi M.

Eur Urol. 2012 May;61(5):994-1003. doi: 10.1016/j.eururo.2012.02.033. Epub 2012 Feb 25. Review.

PMID:
22405510
[PubMed - indexed for MEDLINE]
10.

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia.

Yoshida M, Kudoh J, Homma Y, Kawabe K.

Clin Interv Aging. 2011;6:161-72. doi: 10.2147/CIA.S13803. Epub 2011 Jun 22. Review.

PMID:
21753871
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, MacDonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD001423.

PMID:
19370565
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.

MacDonald R, Tacklind JW, Rutks I, Wilt TJ.

BJU Int. 2012 Jun;109(12):1756-61. doi: 10.1111/j.1464-410X.2012.11172.x. Epub 2012 May 2. Review.

PMID:
22551330
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.

Capitanio U, Salonia A, Briganti A, Montorsi F.

Int J Clin Pract. 2013 Jun;67(6):544-51. doi: 10.1111/ijcp.12135. Epub 2013 Feb 15. Review.

PMID:
23409749
[PubMed - indexed for MEDLINE]
14.

Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review.

Dong Z, Wang Z, Yang K, Liu Y, Gao W, Chen W.

Syst Biol Reprod Med. 2009 Aug;55(4):129-36. doi: 10.3109/19396360902833235. Review.

PMID:
19886768
[PubMed - indexed for MEDLINE]
15.

Silodosin : a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Osman NI, Chapple CR, Cruz F, Desgrandchamps F, Llorente C, Montorsi F.

Expert Opin Pharmacother. 2012 Oct;13(14):2085-96. doi: 10.1517/14656566.2012.714368. Epub 2012 Aug 28. Review.

PMID:
22924980
[PubMed - indexed for MEDLINE]
16.

α-Blockers for benign prostatic hyperplasia: the new era.

Lepor H, Kazzazi A, Djavan B.

Curr Opin Urol. 2012 Jan;22(1):7-15. doi: 10.1097/MOU.0b013e32834d9bfd. Review.

PMID:
22080875
[PubMed - indexed for MEDLINE]
17.

Pygeum africanum for benign prostatic hyperplasia.

Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G.

Cochrane Database Syst Rev. 2002;(1):CD001044. Review.

PMID:
11869585
[PubMed - indexed for MEDLINE]
18.

Microwave thermotherapy for benign prostatic hyperplasia.

Hoffman RM, Monga M, Elliott SP, Macdonald R, Langsjoen J, Tacklind J, Wilt TJ.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD004135. doi: 10.1002/14651858.CD004135.pub3. Review.

PMID:
22972068
[PubMed - indexed for MEDLINE]
19.

Serenoa repens for benign prostatic hyperplasia.

Wilt T, Ishani A, Mac Donald R.

Cochrane Database Syst Rev. 2002;(3):CD001423. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD001423.

PMID:
12137626
[PubMed - indexed for MEDLINE]
20.

Microwave thermotherapy for benign prostatic hyperplasia.

Hoffman RM, Monga M, Elliot SP, Macdonald R, Wilt TJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004135. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD004135.

PMID:
17943811
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk